Clinical trial
Imperial Prostate 4: Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer
NCT04049747 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Imperial Prostate 4: Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer
- Lead sponsor
- Imperial College London
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 11, 2019
- Completion date
- March 20, 2023
- Enrollment
- 100 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
non-metastatic prostate cancer, prostate adenocarcinoma, prostate cancer